Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: An evaluation in the US hospital setting

Julian F. Guest, Francis J. Ruiz, Reiping Tang, Jeng Yi Wang, Chung R. Changchien, Steven Wexner, Michael A. Choti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To estimate the cost implications of blood transfusions and related surgical site infections (SSIs) in cancer patients undergoing elective colorectal resection in the hospital setting in the United States (US). Study design: A modelling study was performed from the perspective of the hospital sector, based on published clinical outcomes from a study in Taiwan involving 2809 cancer patients who underwent elective colorectal resection using laparotomy and American treatment patterns. Methods: Data on resource use were retrieved from published literature and from two American hospital centres specialising in colorectal cancer management. Decision analytical modelling was used to estimate the treatment costs and consequences of managing patients undergoing elective colorectal resection with and without blood transfusions. Results: The expected treatment costs of managing patients who required and did not require a blood transfusion were estimated to be $19869 (95% CI: 15797; 23150) and $14586 (95% CI: 14263; 14886) per patient respectively. Expected treatment costs for those patients transfused with 1-3 units and > 3 units of blood were estimated to be $17449 and $22588 per patient respectively. Conclusion: This is one of the first studies to specifically address the cost implications of post-surgical morbidity following colorectal resection in cancer patients. The cost of managing cancer patients undergoing elective colorectal resection who require a blood transfusion is expected to be 36% more than that of non-transfused patients, largely resulting from the development of SSIs.

Original languageEnglish (US)
Pages (from-to)447-455
Number of pages9
JournalCurrent Medical Research and Opinion
Volume21
Issue number3
DOIs
StatePublished - Mar 2005

Fingerprint

State Hospitals
Blood Transfusion
Morbidity
Costs and Cost Analysis
Neoplasms
Health Care Costs
Surgical Wound Infection
Decision Support Techniques
Taiwan
Laparotomy
Colorectal Neoplasms
Outcome Assessment (Health Care)

Keywords

  • Blood transfusions
  • Colorectal cancer
  • Costs
  • Economics
  • Resource use
  • Surgical site infections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection : An evaluation in the US hospital setting. / Guest, Julian F.; Ruiz, Francis J.; Tang, Reiping; Wang, Jeng Yi; Changchien, Chung R.; Wexner, Steven; Choti, Michael A.

In: Current Medical Research and Opinion, Vol. 21, No. 3, 03.2005, p. 447-455.

Research output: Contribution to journalArticle

Guest, Julian F. ; Ruiz, Francis J. ; Tang, Reiping ; Wang, Jeng Yi ; Changchien, Chung R. ; Wexner, Steven ; Choti, Michael A. / Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection : An evaluation in the US hospital setting. In: Current Medical Research and Opinion. 2005 ; Vol. 21, No. 3. pp. 447-455.
@article{f89f4dde75984235a9ff5879377affe6,
title = "Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: An evaluation in the US hospital setting",
abstract = "Objective: To estimate the cost implications of blood transfusions and related surgical site infections (SSIs) in cancer patients undergoing elective colorectal resection in the hospital setting in the United States (US). Study design: A modelling study was performed from the perspective of the hospital sector, based on published clinical outcomes from a study in Taiwan involving 2809 cancer patients who underwent elective colorectal resection using laparotomy and American treatment patterns. Methods: Data on resource use were retrieved from published literature and from two American hospital centres specialising in colorectal cancer management. Decision analytical modelling was used to estimate the treatment costs and consequences of managing patients undergoing elective colorectal resection with and without blood transfusions. Results: The expected treatment costs of managing patients who required and did not require a blood transfusion were estimated to be $19869 (95{\%} CI: 15797; 23150) and $14586 (95{\%} CI: 14263; 14886) per patient respectively. Expected treatment costs for those patients transfused with 1-3 units and > 3 units of blood were estimated to be $17449 and $22588 per patient respectively. Conclusion: This is one of the first studies to specifically address the cost implications of post-surgical morbidity following colorectal resection in cancer patients. The cost of managing cancer patients undergoing elective colorectal resection who require a blood transfusion is expected to be 36{\%} more than that of non-transfused patients, largely resulting from the development of SSIs.",
keywords = "Blood transfusions, Colorectal cancer, Costs, Economics, Resource use, Surgical site infections",
author = "Guest, {Julian F.} and Ruiz, {Francis J.} and Reiping Tang and Wang, {Jeng Yi} and Changchien, {Chung R.} and Steven Wexner and Choti, {Michael A.}",
year = "2005",
month = "3",
doi = "10.1185/030079905X30734",
language = "English (US)",
volume = "21",
pages = "447--455",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection

T2 - An evaluation in the US hospital setting

AU - Guest, Julian F.

AU - Ruiz, Francis J.

AU - Tang, Reiping

AU - Wang, Jeng Yi

AU - Changchien, Chung R.

AU - Wexner, Steven

AU - Choti, Michael A.

PY - 2005/3

Y1 - 2005/3

N2 - Objective: To estimate the cost implications of blood transfusions and related surgical site infections (SSIs) in cancer patients undergoing elective colorectal resection in the hospital setting in the United States (US). Study design: A modelling study was performed from the perspective of the hospital sector, based on published clinical outcomes from a study in Taiwan involving 2809 cancer patients who underwent elective colorectal resection using laparotomy and American treatment patterns. Methods: Data on resource use were retrieved from published literature and from two American hospital centres specialising in colorectal cancer management. Decision analytical modelling was used to estimate the treatment costs and consequences of managing patients undergoing elective colorectal resection with and without blood transfusions. Results: The expected treatment costs of managing patients who required and did not require a blood transfusion were estimated to be $19869 (95% CI: 15797; 23150) and $14586 (95% CI: 14263; 14886) per patient respectively. Expected treatment costs for those patients transfused with 1-3 units and > 3 units of blood were estimated to be $17449 and $22588 per patient respectively. Conclusion: This is one of the first studies to specifically address the cost implications of post-surgical morbidity following colorectal resection in cancer patients. The cost of managing cancer patients undergoing elective colorectal resection who require a blood transfusion is expected to be 36% more than that of non-transfused patients, largely resulting from the development of SSIs.

AB - Objective: To estimate the cost implications of blood transfusions and related surgical site infections (SSIs) in cancer patients undergoing elective colorectal resection in the hospital setting in the United States (US). Study design: A modelling study was performed from the perspective of the hospital sector, based on published clinical outcomes from a study in Taiwan involving 2809 cancer patients who underwent elective colorectal resection using laparotomy and American treatment patterns. Methods: Data on resource use were retrieved from published literature and from two American hospital centres specialising in colorectal cancer management. Decision analytical modelling was used to estimate the treatment costs and consequences of managing patients undergoing elective colorectal resection with and without blood transfusions. Results: The expected treatment costs of managing patients who required and did not require a blood transfusion were estimated to be $19869 (95% CI: 15797; 23150) and $14586 (95% CI: 14263; 14886) per patient respectively. Expected treatment costs for those patients transfused with 1-3 units and > 3 units of blood were estimated to be $17449 and $22588 per patient respectively. Conclusion: This is one of the first studies to specifically address the cost implications of post-surgical morbidity following colorectal resection in cancer patients. The cost of managing cancer patients undergoing elective colorectal resection who require a blood transfusion is expected to be 36% more than that of non-transfused patients, largely resulting from the development of SSIs.

KW - Blood transfusions

KW - Colorectal cancer

KW - Costs

KW - Economics

KW - Resource use

KW - Surgical site infections

UR - http://www.scopus.com/inward/record.url?scp=16844361866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844361866&partnerID=8YFLogxK

U2 - 10.1185/030079905X30734

DO - 10.1185/030079905X30734

M3 - Article

C2 - 15811214

AN - SCOPUS:16844361866

VL - 21

SP - 447

EP - 455

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 3

ER -